Skip to content

Safety and Efficacy Study of Pain Shield Device to Treat Subjects Following Laparoscopic-Assisted Abdominal Surgery

Evaluation of Safety and Efficacy of the PainShield Device for the Treatment of Subjects Who Underwent Laparoscopic-Assisted Abdominal Surgery

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00737425
Enrollment
80
Registered
2008-08-19
Start date
2008-09-30
Completion date
Unknown
Last updated
2008-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wounds

Keywords

laparoscopic-assisted surgery, abdominal, pain relief, wound healing, low intensity ultrasound

Brief summary

The purpose of this study is to evaluate safety and efficacy of PainShield device, based on ultrasound technology, for postoperative pain relief and wound healing following a laparoscopic-assisted abdominal surgery.

Interventions

DEVICEPainShield
DEVICESham PainShield

Sponsors

Nanovibronix
CollaboratorINDUSTRY
Shaare Zedek Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject's Age ≥ 18 * Subject is able, agrees and signs the Informed Consent Form * Subject requires laparoscopic-assisted abdominal surgery * Incision size following the laparoscopy between 4-7 cm

Exclusion criteria

* Epidural analgesia * IV PCA * Subject has any condition, which precludes compliance with study and/or device instructions * Subject is currently participating in another clinical study.

Design outcomes

Primary

MeasureTime frame
Pain and discomfort will be measured using appropriate validated questionnaires.Pain assessment will be performed daily

Secondary

MeasureTime frame
Infections will be assessed by concomitant antibiotic intakeConcomitant medications will be assessed daily

Countries

Israel

Contacts

Primary ContactPetachia Reissman, MD
+972 2 6666310
Backup ContactEran Lavi, MD
+972 2 6666310

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026